Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.52
-0.24 (-4.17%)
Mar 3, 2026, 4:00 PM EST - Market closed

Foghorn Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
24.5222.634.1619.231.320.43
Revenue Growth (YoY)
-3.91%-33.83%77.63%1357.77%206.74%-
Gross Profit
24.5222.634.1619.231.320.43
Selling, General & Admin
27.1128.3632.3730.7521.7311.25
Research & Development
83.9394.53109.69105.6280.3357.72
Other Operating Expenses
-2.4----
Total Operating Expenses
111.03125.29142.06136.37102.0568.96
Operating Income
-86.52-102.68-107.91-117.14-100.73-68.53
Interest Income
10.1311.910.885.680.06-
Interest Expense
-----1.91-0.98
Other Non-Operating Income (Expense)
4.274.162.832.583.731.15
Total Non-Operating Income (Expense)
14.3916.0613.718.261.880.18
Pretax Income
-72.12-86.62-94.2-108.88-98.85-68.36
Provision for Income Taxes
---4.23---
Net Income
-72.12-86.62-98.43-108.88-101.32-68.8
Net Income to Common
-72.12-86.62-98.43-108.88-101.32-68.8
Shares Outstanding (Basic)
635542423711
Shares Outstanding (Diluted)
635542423711
Shares Change (YoY)
26.60%30.79%0.92%11.89%236.49%163.53%
EPS (Basic)
-1.13-1.58-2.34-2.62-2.73-6.23
EPS (Diluted)
-1.13-1.58-2.34-2.62-2.73-6.23
Free Cash Flow
-88.88-101.31-119.33192.4-53.56-47.47
Free Cash Flow Per Share
-1.41-1.85-2.844.63-1.44-4.30
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-352.87%-454.31%-315.93%-609.20%-7637.15%-15937.44%
Profit Margin
-294.16%-383.24%-263.43%-566.27%-7494.62%-15896.74%
FCF Margin
-362.49%-448.24%-349.38%1000.63%-4060.88%-11039.30%
EBITDA
-83.23-99.56-104.46-113.82-97.51-67.2
EBITDA Margin
-339.44%-440.51%-305.83%-591.93%-7392.49%-15628.84%
EBIT
-86.52-102.68-107.91-117.14-100.73-68.53
EBIT Margin
-352.87%-454.31%-315.93%-609.20%-7637.15%-15937.44%
Effective Tax Rate
-0.00%4.49%0.00%0.00%0.00%
Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q